Skip to main content
Veterinary Medicines

Zantoral 30mg/ml oral solution for dogs

Authorised
  • Ranitidine

Product identification

Medicine name:
Zantoral 30mg/ml oral solution for dogs
Active substance:
  • Ranitidine
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Ranitidine
    30.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BA02
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • High density polyethylene bottle 48 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
  • High density polyethylene bottle 24 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.
  • High density polyethylene bottle 12 ml with high density polyethylene stoppers and a low density polyethylene plug. 3 ml polypropylene/silicone syringe, graduated every 0.1 ml to 3 ml.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 105328
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0141/001
Concerned member states:
  • Austria
  • Belgium
  • Germany
  • Luxembourg
  • Netherlands

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 10/10/2024